Summary:

Join our dynamic research team focused on advancing cell-based immunotherapies. Collaborate with an experienced immunologist to identify and genetically modify HLA surface receptors on CD34+ and LSK cells. Utilize your expertise in cell culture, genetic engineering, and flow cytometry to characterize these modifications and contribute to the development of novel cell therapies. Successful outcomes may lead to exciting opportunities (and employment) to participate in pre-clinical studies and play a role in advancing these therapies toward clinical trials.

Key Responsibilities:

• Culture and expand CD34+ and LSK cells under controlled conditions.
• Perform genetic engineering techniques to modify HLA surface receptors.
• Conduct flow cytometry assays to characterize receptor expression and cell phenotypes.
• Analyze and interpret experimental data, and present findings to the team.
• Maintain accurate and detailed laboratory records.
• Contribute to the preparation of scientific publications and presentations.

Qualifications:

• Bachelor's or Master's degree in a relevant field (e.g., biology, cell biology, immunology).
• Hands-on experience in cell culture, genetic engineering techniques (e.g., CRISPR/Cas9), and flow cytometry.
• Strong analytical and problem-solving skills.
• Excellent communication and teamwork abilities.
• A passion for scientific research and the development of novel therapies.

Benefits:

• Be part of a cutting-edge research team pushing the boundaries of cell-based therapies.
• Gain valuable experience in genetic engineering, immunology, and pre-clinical research.
• Contribute to the development of potentially life-saving treatments.
• Work in a collaborative and supportive environment.

Compensation:

$19-24 per hour

To Apply:

Please submit your resume, cover letter, and contact information for three references to [email protected]

This description provides a clear overview of the position, highlights the key responsibilities and qualifications, and emphasizes the potential for growth and impact.